Abbott said Thursday it received Europe’s CE mark sooner than anticipated for its Volt pulsed field ablation system to treat atrial fibrillation. The company has started commercial PFA cases in ...

Lingo is part of Abbott’s healthcare businesses and products that also cover nutrition, medicine, diagnostics, and medical devices, which help people live more fully at all stages of life. People ...

Abbott Laboratories beat third-quarter profit and sales estimates on strong demand for its medical devices. Sales were also higher at its pharmaceutical unit, but fell at its diagnostics and ...

Given its better prospects, we believe Abbott stock (NYSE: ABT) is a better pick than its peer Medtronic stock (NYSE: MDT). ABT stock trades at 4.9x trailing revenues, versus 3.6x for MDT ...

Medtronic, Abbott strike diabetes devices deal, giving patients more options. Analysts see the partnership as positive for Medtronic, which has had some stumbles in its diabetes division.

KFF Health News found records of Abbott payments associated with 10 of the 14 voting members of the FDA advisory panel, which was weighing clinical evidence for a heart device called TriClip G4 ...

(Reuters) -Abbott Laboratories said on Tuesday the U.S. FDA has approved its heart valve repair device for patients with a potentially fatal heart disease, just months after rival Edwards ...

There were 7 (2.5%) total device embolizations, 5 (1.8%) of which were with the MVP and 2 (0.7%) with the Piccolo device. Of the 7 devices that embolized, 6 went to the pulmonary arteries and 1 to the ...

Within Abbott’s medical device portfolio, the company saw worldwide sales growth across the board, totaling $4.25 billion for a 16.6% boost over last year. Related.